• Profile
Close

Prevalence, presentation and treatment of ‘balloon undilatable’ chronic total occlusions: Insights from a multicenter US registry

Catheterization and Cardiovascular Interventions Jan 26, 2018

Tajti P, et al. - Researchers conducted this study to assess the prevalence, treatment and outcomes of balloon undilatable chronic total occlusions (CTOs). Findings revealed a common occurrence of balloon undilatable CTOs. These were associated with lower success and higher complication rates.

Methods

  • In a contemporary multicenter US registry, the prevalence, clinical and angiographic characteristics, and procedural outcomes of percutaneous coronary interventions (PCIs) for balloon undilatable CTOs were examined.

Results

  • Between 2012 and 2017, data on balloon undilatable lesions were available for 425 consecutive CTO PCIs in 415 patients.
  • Among them guidewire crossing was successful: 52 of 425 CTOs were balloon undilatable (12%).
  • Mean patient age was 65 ± 10 years.
  • The patients were men (84%) in majority.
  • Among patients with balloon undilatable CTOs, more frequent diabetes (67 vs 41%, P < 0.001) and heart failure (44 vs 28%, P=0.027) were observed.
  • Findings revealed that balloon undilatable CTOs were longer (40 mm [interquartile range, IQR 20-50] vs 30 [IQR 15-40], P=0.016), more frequently had moderate/severe calcification (87 vs 54%, P < 0.001), and had higher J-CTO score (3.2 ± 1.1 vs 2.5 ± 1.3, P < 0.001) and PROGRESS-CTO complications score (3.9 ± 1.7 vs 3.1 ± 2.0, P < 0.005).
  • They were found to be associated with lower technical and procedural success (92 vs 98%, P=0.024; and 88 vs 96%, P=0.034, respectively) and due to higher perforation rates, also had higher risk for in-hospital major adverse events (8 vs 2%, P=0.008).
  • High pressure balloon inflations (64%), rotational atherectomy (31%), laser (21%), and cutting balloons (15%) were the most frequent treatments for balloon undilatable CTOs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay